Literature DB >> 31087789

Primary adrenal gland epithelioid sarcoma: A case report and literature review.

Xiao Huang1, Ritu Nayar1, Haijun Zhou2.   

Abstract

Epithelioid sarcoma is a malignant mesenchymal neoplasm with morphologic and immunophenotypic epithelioid differentiation, which rarely arises in solid organs. We report a case of primary epithelioid sarcoma in the adrenal gland of a 31-year-old female. The patient initially presented with nausea and rectal bleeding, and subsequent imaging studies revealed a 4.4 cm left adrenal gland mass and left retroperitoneal lymphadenopathy. Clinical and radiological studies did not reveal tumor elsewhere in the patient. Histologic features were those of epithelioid sarcoma, proximal type with cohesive clusters of epithelioid tumor cells harboring frequent mitoses, and areas of necrosis. Immunohistochemical stains showed strong, diffuse expression of epithelial markers (pancytokeratin), and CD34 and Fli-1. Partial and focal positive staining of CK7 was also noted. Nuclear expression of SMARCB1 (INI-1) protein was lost. ERG was negative in this case. We believe that this is the second-case report of a primary adrenal gland epithelioid sarcoma. Fli-1 positivity was seen in our case, and ERG was negative as shown in some recent publications regarding epithelioid sarcomas.
© 2019 Wiley Periodicals, Inc.

Entities:  

Keywords:  INI-1; adrenal gland; epithelioid sarcoma; needle biopsy

Mesh:

Substances:

Year:  2019        PMID: 31087789     DOI: 10.1002/dc.24211

Source DB:  PubMed          Journal:  Diagn Cytopathol        ISSN: 1097-0339            Impact factor:   1.582


  2 in total

1.  An Adrenal SMARCB1/INI1 Deficient Proximal Epithelioid Sarcoma in a Middle-Aged Female: A Case Report.

Authors:  Zachary Brodie; Erin McCartney; Sergio Toledo
Journal:  Cureus       Date:  2022-09-16

2.  Response to immunotherapy in a patient with advanced epithelioid sarcoma of adrenal gland: A case report.

Authors:  Jingwen Wang; Chen Lu; Xi Tang
Journal:  Exp Ther Med       Date:  2022-09-07       Impact factor: 2.751

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.